PLA micro- and nano-particles

Advanced Drug Delivery Reviews

Volumn 107, Issue , 2016, Pages 176-191

  Lee, Byung Kook ^a   Yun, Yeonhee ^a   Park, Kinam ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

Drug delivery system; Fabrication methods; Micro particles; Nano particles; PLA

Indexed keywords

BIOCOMPATIBILITY; EMULSIFICATION; ENCAPSULATION; GENE THERAPY; LACTIC ACID; MEDICAL APPLICATIONS; NANOPARTICLES; PRECIPITATION (CHEMICAL); TARGETED DRUG DELIVERY;

BIOMEDICAL APPLICATIONS; CONTROLLED DRUG DELIVERY SYSTEMS; DRUG DELIVERY SYSTEM; ENCAPSULATION EFFICIENCY; FABRICATION METHOD; MICRO AND NANO-PARTICLE; MICRO PARTICLES; POLY (D , L LACTIC ACID);

CONTROLLED DRUG DELIVERY;

ANTINEOPLASTIC AGENT; DRUG; DRUG CARRIER; NANOPARTICLE; POLYLACTIC ACID; PROTEIN; POLYESTER; POLYLACTIDE;

BIOCOMPATIBILITY; BIODEGRADABILITY; CHEMICAL ANALYSIS; CHEMICAL PROCEDURES; CONTROLLED DRUG RELEASE; DRUG DELIVERY SYSTEM; EMULSION; ENCAPSULATION; GENE DELIVERY SYSTEM; IN SITU FORMING MICROPARTICLE; MELTING TECHNIQUE; MICROFLUIDICS; PRECIPITATION; PRIORITY JOURNAL; REVIEW; SALTING OUT; SPRAY DRYING; SUPERCRITICAL FLUID; TEMPLATE MOLD BASED TECHNIQUE; TERMINAL STERILIZATION; ANIMAL; CHEMISTRY; DRUG FORMULATION; HUMAN; MEDICINAL CHEMISTRY;

ANIMALS; CHEMISTRY, PHARMACEUTICAL; DRUG CARRIERS; DRUG COMPOUNDING; HUMANS; NANOPARTICLES; POLYESTERS;

EID: 84977483136     PISSN: 0169409X     EISSN: 18728294     Source Type: Journal    
DOI: 10.1016/j.addr.2016.05.020     Document Type: Review

References (153)

1. [1] Freiberg, S., Zhu, X.X., Polymer microspheres for controlled drug release. Int. J. Pharm. 282 (2004), 1–18.
2. [2] Kamaly, N., Xiao, Z., Valencia, P.M., Radovic-Moreno, A.F., Farokhzad, O.C., Targeted polymeric therapeutic nanoparticles: design, development and clinical translation. Chem. Soc. Rev. 41 (2012), 2971–3010.
3. [3] Stloukal, P., Kucharczyk, P., Sedlarik, V., Bazant, P., Koutny, M., Low molecular weight poly(lactic acid) microparticles for controlled release of the herbicide metazachlor: preparation, morphology, and release kinetics. J. Agric. Food Chem. 60 (2012), 4111–4119.
4. [4] Thomasin, C., Merkle, H.P., Gander, B., Drug microencapsulation by PLA/PLGA coacervation in the light of thermodynamics. 2. Parameters determining microsphere formation. J. Pharm. Sci. 87 (1998), 269–275.
5. [5] Lassalle, V., Ferreira, M.L., PLA nano- and microparticles for drug delivery: an overview of the methods of preparation. Macromol. Biosci. 7 (2007), 767–783.
6. [6] Allouche, J., Synthesis of organic and bioorganic nanoparticles: an overview of the preparation methods. Brayner, R., Fiévet, F., Coradin, T., (eds.) Nanomaterials: A Danger or a Promise?, 2013, Springer, London, 27–74.
7. [7] Kumar, G., Shafiq, N., Malhotra, S., Drug-loaded PLGA nanoparticles for oral administration: fundamental issues and challenges ahead. Crit. Rev. Ther. Drug Carrier Syst. 29 (2012), 149–182.
8. [8] Mitragotri, S., Burke, P.A., Langer, R., Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies. Nat. Rev. Drug Discov. 13 (2014), 655–672.
9. [9] Madhavan Nampoothiri, K., Nair, N.R., John, R.P., An overview of the recent developments in polylactide (PLA) research. Bioresour. Technol. 101 (2010), 8493–8501.
10. [10] Bala, I., Hariharan, S., Kumar, M.N., PLGA nanoparticles in drug delivery: the state of the art. Crit. Rev. Ther. Drug Carrier Syst. 21 (2004), 387–422.
11. [11] Soppimath, K.S., Aminabhavi, T.M., Kulkarni, A.R., Rudzinski, W.E., Biodegradable polymeric nanoparticles as drug delivery devices. J. Control. Release 70 (2001), 1–20.
12. [12] Anderson, J.M., Shive, M.S., Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv. Drug Deliv. Rev. 64 (2012), 72–82 (Supplement).
13. [13] Danhier, F., Ansorena, E., Silva, J.M., Coco, R., Le Breton, A., Preat, V., PLGA-based nanoparticles: an overview of biomedical applications. J. Control. Release 161 (2012), 505–522.
14. [14] Pagels, R.F., Prud'homme, R.K., Polymeric nanoparticles and microparticles for the delivery of peptides, biologics, and soluble therapeutics. J. Control. Release 219 (2015), 519–535.
15. [15] Zhao, C.-X., Multiphase flow microfluidics for the production of single or multiple emulsions for drug delivery. Adv. Drug Deliv. Rev. 65 (2013), 1420–1446.
16. [16] Coelho, J.F., Ferreira, P.C., Alves, P., Cordeiro, R., Fonseca, A.C., Góis, J.R., Gil, M.H., Drug delivery systems: advanced technologies potentially applicable in personalized treatments. EPMA J. 1 (2010), 164–209.
17. [17] Wischke, C., Schwendeman, S.P., Principles of encapsulating hydrophobic drugs in PLA/PLGA microparticles. Int. J. Pharm. 364 (2008), 298–327.
18. [18] Freitas, S., Merkle, H.P., Gander, B., Microencapsulation by solvent extraction/evaporation: reviewing the state of the art of microsphere preparation process technology. J. Control. Release 102 (2005), 313–332.
19. [19] Rao, J.P., Geckeler, K.E., Polymer nanoparticles: preparation techniques and size-control parameters. Prog. Polym. Sci. 36 (2011), 887–913.
20. [20] Lin, Y.M., Zhang, A., Rippon, H.J., Bismarck, A., Bishop, A.E., Tissue engineering of lung: the effect of extracellular matrix on the differentiation of embryonic stem cells to pneumocytes. Tissue Eng. A 16 (2010), 1515–1526.
21. [21] Mainardes, R.M., Gremiao, M.P., Brunetti, I.L., da Fonseca, L.M., Khalil, N.M., Zidovudine-loaded PLA and PLA–PEG blend nanoparticles: influence of polymer type on phagocytic uptake by polymorphonuclear cells. J. Pharm. Sci. 98 (2009), 257–267.
22. [22] Xing, J., Zhang, D., Tan, T., Studies on the oridonin-loaded poly(D,L-lactic acid) nanoparticles in vitro and in vivo. Int. J. Biol. Macromol. 40 (2007), 153–158.
23. [23] Gao, H., Wang, Y.N., Fan, Y.G., Ma, J.B., Synthesis of a biodegradable tadpole-shaped polymer via the coupling reaction of polylactide onto mono(6-(2-aminoethyl)amino-6-deoxy)-beta-cyclodextrin and its properties as the new carrier of protein delivery system. J. Control. Release 107 (2005), 158–173.
24. [24] Zhang, Z., Feng, S.-S., Nanoparticles of poly(lactide)/vitamin E TPGS copolymer for cancer chemotherapy: synthesis, formulation, characterization and in vitro drug release. Biomaterials 27 (2006), 262–270.
25. [25] Ataman-Onal, Y., Munier, S., Ganee, A., Terrat, C., Durand, P.Y., Battail, N., Martinon, F., Le Grand, R., Charles, M.H., Delair, T., Verrier, B., Surfactant-free anionic PLA nanoparticles coated with HIV-1 p24 protein induced enhanced cellular and humoral immune responses in various animal models. J. Control. Release 112 (2006), 175–185.
26. [26] Leo, E., Brina, B., Forni, F., Vandelli, M.A., In vitro evaluation of PLA nanoparticles containing a lipophilic drug in water-soluble or insoluble form. Int. J. Pharm. 278 (2004), 133–141.
27. [27] Kranz, H., Brazeau, G.A., Napaporn, J., Martin, R.L., Millard, W., Bodmeier, R., Myotoxicity studies of injectable biodegradable in-situ forming drug delivery systems. Int. J. Pharm. 212 (2001), 11–18.
28. [28] Makadia, H.K., Siegel, S.J., Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier. Polymers 3 (2011), 1377–1397.
29. [29] Sadat Tabatabaei Mirakabad, F., Nejati-Koshki, K., Akbarzadeh, A., Yamchi, M.R., Milani, M., Zarghami, N., Zeighamian, V., Rahimzadeh, A., Alimohammadi, S., Hanifehpour, Y., Joo, S.W., PLGA-based nanoparticles as cancer drug delivery systems. Asian Pac. J. Cancer Prev. 15 (2014), 517–535.
30. [30] Sah, E., Sah, H., Recent trends in preparation of poly(lactide-co-glycolide) nanoparticles by mixing polymeric organic solution with antisolvent. J. Nanomater., 2015, 2015, 22.
31. [31] Quintanar-Guerrero, D., Allemann, E., Fessi, H., Doelker, E., Preparation techniques and mechanisms of formation of biodegradable nanoparticles from preformed polymers. Drug Dev. Ind. Pharm. 24 (1998), 1113–1128.
32. [32] Martín-Sabroso, C., Fraguas-Sánchez, A.I., Aparicio-Blanco, J., Cano-Abad, M.F., Torres-Suárez, A.I., Critical attributes of formulation and of elaboration process of PLGA-protein microparticles. Int. J. Pharm. 480 (2015), 27–36.
33. [33] Li, M., Rouaud, O., Poncelet, D., Microencapsulation by solvent evaporation: state of the art for process engineering approaches. Int. J. Pharm. 363 (2008), 26–39.
34. [34] Tan, M.X.L., Danquah, M.K., Drug and protein encapsulation by emulsification: technology enhancement using foam formulations. Chem. Eng. Technol. 35 (2012), 618–626.
35. [35] Jain, R.A., The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices. Biomaterials 21 (2000), 2475–2490.
36. [36] Lamprecht, A., Ubrich, N., Hombreiro Pérez, M., Lehr, C.M., Hoffman, M., Maincent, P., Biodegradable monodispersed nanoparticles prepared by pressure homogenization-emulsification. Int. J. Pharm. 184 (1999), 97–105.
37. [37] Zambaux, M.F., Bonneaux, F., Gref, R., Maincent, P., Dellacherie, E., Alonso, M.J., Labrude, P., Vigneron, C., Influence of experimental parameters on the characteristics of poly(lactic acid) nanoparticles prepared by a double emulsion method. J. Control. Release 50 (1998), 31–40.
38. [38] Lu, J.M., Wang, X., Marin-Muller, C., Wang, H., Lin, P.H., Yao, Q., Chen, C., Current advances in research and clinical applications of PLGA-based nanotechnology. Expert. Rev. Mol. Diagn. 9 (2009), 325–341.
39. [39] Bragagni, M., Beneitez, C., Martín, C., de la Ossa, D.H.P., Mura, P.A., Gil-Alegre, M.E., Selection of PLA polymers for the development of injectable prilocaine controlled release microparticles: usefulness of thermal analysis. Int. J. Pharm. 441 (2013), 468–475.
40. [40] Jung, T., Kamm, W., Breitenbach, A., Kaiserling, E., Xiao, J.X., Kissel, T., Biodegradable nanoparticles for oral delivery of peptides: is there a role for polymers to affect mucosal uptake?. Eur. J. Pharm. Biopharm. 50 (2000), 147–160.
41. [41] Lambert, G., Fattal, E., Couvreur, P., Nanoparticulate systems for the delivery of antisense oligonucleotides. Adv. Drug Deliv. Rev. 47 (2001), 99–112.
42. [42] Ghaderi, R., Artursson, P., Carlfors, J., A new method for preparing biodegradable microparticles and entrapment of hydrocortisone in dl-PLG microparticles using supercritical fluids. Eur. J. Pharm. Sci. 10 (2000), 1–9.
43. [43] Allémann, E., Gurny, R., Doelker, E., Preparation of aqueous polymeric nanodispersions by a reversible salting-out process: influence of process parameters on particle size. Int. J. Pharm. 87 (1992), 247–253.
44. [44] Govender, T., Stolnik, S., Garnett, M.C., Illum, L., Davis, S.S., PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug. J. Control. Release 57 (1999), 171–185.
45. [45] Barichello, J.M., Morishita, M., Takayama, K., Nagai, T., Absorption of insulin from Pluronic F-127 gels following subcutaneous administration in rats. Int. J. Pharm. 184 (1999), 189–198.
46. [46] Francois, G., Katz, J.L., Nanoparticles and nanocapsules created using the Ouzo effect: spontaneous emulisification as an alternative to ultrasonic and high-shear devices. ChemPhysChem 6 (2005), 209–216.
47. [47] Vitale, S.A., Katz, J.L., Liquid droplet dispersions formed by homogeneous liquid–liquid nucleation: “the ouzo effect”. Langmuir 19 (2003), 4105–4110.
48. [48] Anton, N., Benoit, J.P., Saulnier, P., Design and production of nanoparticles formulated from nano-emulsion templates-a review. J. Control. Release 128 (2008), 185–199.
49. [49] Zhu, D., Tao, W., Zhang, H., Liu, G., Wang, T., Zhang, L., Zeng, X., Mei, L., Docetaxel (DTX)-loaded polydopamine-modified TPGS-PLA nanoparticles as a targeted drug delivery system for the treatment of liver cancer. Acta Biomater. 30 (2016), 144–154.
50. [50] Kostag, M., Köhler, S., Liebert, T., Heinze, T., Pure cellulose nanoparticles from Trimethylsilyl cellulose. Macromol. Symp. 294 (2010), 96–106.
51. [51] Chronopoulou, L., Fratoddi, I., Palocci, C., Venditti, I., Russo, M.V., Osmosis based method drives the self-assembly of polymeric chains into micro- and nanostructures. Langmuir 25 (2009), 11940–11946.
52. [52] Na, K., Lee, K.H., Lee, D.H., Bae, Y.H., Biodegradable thermo-sensitive nanoparticles from poly(l-lactic acid)/poly(ethylene glycol) alternating multi-block copolymer for potential anti-cancer drug carrier. Eur. J. Pharm. Sci. 27 (2006), 115–122.
53. [53] Hornig, S., Heinze, T., Efficient approach to design stable water-dispersible nanoparticles of hydrophobic cellulose esters. Biomacromolecules 9 (2008), 1487–1492.
54. [54] Jeong, Y.-I., Cho, C.-S., Kim, S.-H., Ko, K.-S., Kim, S.-I., Shim, Y.-H., Nah, J.-W., Preparation of poly(DL-lactide-co-glycolide) nanoparticles without surfactant. J. Appl. Polym. Sci. 80 (2001), 2228–2236.
55. [55] Liu, W., Chen, X.D., Selomulya, C., On the spray drying of uniform functional microparticles. Particuology 22 (2015), 1–12.
56. [56] Bodmeier, R., Chen, H.G., Preparation of biodegradable poly(+/−)lactide microparticles using a spray-drying technique. J. Pharm. Pharmacol. 40 (1988), 754–757.
57. [57] Sosnik, A., Seremeta, K.P., Advantages and challenges of the spray-drying technology for the production of pure drug particles and drug-loaded polymeric carriers. Adv. Colloid Interf. Sci. 223 (2015), 40–54.
58. [58] Chavalitkul, J., Likittanaprasong, N., Seansala, P., Suttiruengwong, S., Seadan, M., Application of ultrasonic atomization for biopolymer particles and tube fabrication. Energy Procedia 56 (2014), 458–465.
59. [59] Pavanetto, F., Genta, I., Giunchedi, P., Conti, B., Evaluation of spray drying as a method for polylactide and polylactide-co-glycolide microsphere preparation. J. Microencapsul. 10 (1993), 487–497.
60. [60] Wagenaar, B.W., Müller, B.W., Piroxicam release from spray-dried biodegradable microspheres. Biomaterials 15 (1994), 49–54.
61. [61] Benelli, P., Conti, B., Genta, I., Costantini, M., Montanari, L., Clonazepam microencapsulation in poly-D,L-lactide-co-glycolide microspheres. J. Microencapsul. 15 (1998), 431–443.
62. [62] Mu, L., Feng, S.S., Fabrication, characterization and in vitro release of paclitaxel (Taxol) loaded poly (lactic-co-glycolic acid) microspheres prepared by spray drying technique with lipid/cholesterol emulsifiers. J. Control. Release 76 (2001), 239–254.
63. [63] Mu, L., Teo, M.-M., Ning, H.-Z., Tan, C.-S., Feng, S.-S., Novel powder formulations for controlled delivery of poorly soluble anticancer drug: application and investigation of TPGS and PEG in spray-dried particulate system. J. Control. Release 103 (2005), 565–575.
64. [64] Lacasse, F.X., Hildgen, P., McMullen, J.N., Surface and morphology of spray-dried pegylated PLA microspheres. Int. J. Pharm. 174 (1998), 101–109.
65. [65] Royals, M.A., Fujita, S.M., Yewey, G.L., Rodriguez, J., Schultheiss, P.C., Dunn, R.L., Biocompatibility of a biodegradable in situ forming implant system in rhesus monkeys. J. Biomed. Mater. Res. 45 (1999), 231–239.
66. [66] Jain, R.A., Rhodes, C.T., Railkar, A.M., Malick, A.W., Shah, N.H., Comparison of various injectable protein-loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices: in-situ-formed implant versus in-situ-formed microspheres versus isolated microspheres. Pharm. Dev. Technol. 5 (2000), 201–207.
67. [67] Luan, X., Bodmeier, R., In situ forming microparticle system for controlled delivery of leuprolide acetate: influence of the formulation and processing parameters. Eur. J. Pharm. Sci. 27 (2006), 143–149.
68. [68] Wichert, B., Rohdewald, P., A new method for the preparation of drug containing polylactic acid microparticles without using organic solvents. J. Control. Release 14 (1990), 269–283.
69. [69] Pinto Reis, C., Neufeld, R.J., Ribeiro, A.J., Veiga, F., Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles. Nanomed. Nanotechnol. Biol. Med. 2 (2006), 8–21.
70. [70] Davies, O.R., Lewis, A.L., Whitaker, M.J., Tai, H., Shakesheff, K.M., Howdle, S.M., Applications of supercritical CO2 in the fabrication of polymer systems for drug delivery and tissue engineering. Adv. Drug Deliv. Rev. 60 (2008), 373–387.
71. [71] Kim, J.-H., Paxton, T.E., Tomasko, D.L., Microencapsulation of naproxen using rapid expansion of supercritical solutions. Biotechnol. Prog. 12 (1996), 650–661.
72. [72] Y. Yeo, N. Baek, K. Park, Microencapsulation methods for delivery of protein drugs, Biotechnol. Bioprocess Eng., 6 (2001) 213–230.
73. [73] Sacchetin, P.S.C., Morales, A.R., Moraes, Â.M., Rosa, P.d.T.V.e., Formation of PLA particles incorporating 17α-methyltestosterone by supercritical fluid technology. J. Supercrit. Fluids 77 (2013), 52–62.
74. [74] Watanabe, T., Ono, T., Kimura, Y., Continuous fabrication of monodisperse polylactide microspheres by droplet-to-particle technology using microfluidic emulsification and emulsion-solvent diffusion. Soft Matter 7 (2011), 9894–9897.
75. [75] Liao, C.Y., Su, Y.C., Formation of biodegradable microcapsules utilizing 3D, selectively surface-modified PDMS microfluidic devices. Biomed. Microdevices 12 (2010), 125–133.
76. [76] Jyothi, N.V., Prasanna, P.M., Sakarkar, S.N., Prabha, K.S., Ramaiah, P.S., Srawan, G.Y., Microencapsulation techniques, factors influencing encapsulation efficiency. J. Microencapsul. 27 (2010), 187–197.
77. [77] Vladisavljević, G.T., Shahmohamadi, H., Das, D.B., Ekanem, E.E., Tauanov, Z., Sharma, L., Glass capillary microfluidics for production of monodispersed poly (dl-lactic acid) and polycaprolactone microparticles: experiments and numerical simulations. J. Colloid Interface Sci. 418 (2014), 163–170.
78. [78] Xu, Q., Hashimoto, M., Dang, T.T., Hoare, T., Kohane, D.S., Whitesides, G.M., Langer, R., Anderson, D.G., Preparation of monodisperse biodegradable polymer microparticles using a microfluidic flow-focusing device for controlled drug delivery. Small 5 (2009), 1575–1581.
79. [79] Acharya, G., Shin, C.S., McDermott, M., Mishra, H., Park, H., Kwon, I.C., Park, K., The hydrogel template method for fabrication of homogeneous nano/microparticles. J. Control. Release 141 (2010), 314–319.
80. [80] Lu, Y., Sturek, M., Park, K., Microparticles produced by the hydrogel template method for sustained drug delivery. Int. J. Pharm. 461 (2014), 258–269.
81. [81] K. Park, S.M. Skidmore, L. Fultz, Y. Yun, B.k. Lee, Device for Large-Scale Microparticle Production and Method of Using the Same, Patent Pending; 2014.
82. [82] Takeuchi, H., Yamamoto, H., Kawashima, Y., Mucoadhesive nanoparticulate systems for peptide drug delivery. Adv. Drug Deliv. Rev. 47 (2001), 39–54.
83. [83] Hsu, C.H., Cui, Z., Mumper, R.J., Jay, M., Preparation and characterization of novel coenzyme Q10 nanoparticles engineered from microemulsion precursors. AAPS PharmSciTech, 4, 2003, E32.
84. [84] Murakami, H., Kobayashi, M., Takeuchi, H., Kawashima, Y., Utilization of poly(dl-lactide-co-glycolide) nanoparticles for preparation of mini-depot tablets by direct compression. J. Control. Release 67 (2000), 29–36.
85. [85] Dwarki, V.J., Belloni, P., Nijjar, T., Smith, J., Couto, L., Rabier, M., Clift, S., Berns, A., Cohen, L.K., Gene therapy for hemophilia a: production of therapeutic levels of human factor VIII in vivo in mice. Proc. Natl. Acad. Sci. U. S. A. 92 (1995), 1023–1027.
86. [86] Chen, J., Tian, B., Yin, X., Zhang, Y., Hu, D., Hu, Z., Liu, M., Pan, Y., Zhao, J., Li, H., Hou, C., Wang, J., Zhang, Y., Preparation, characterization and transfection efficiency of cationic PEGylated PLA nanoparticles as gene delivery systems. J. Biotechnol. 130 (2007), 107–113.
87. [87] Munier, S., Messai, I., Delair, T., Verrier, B., Ataman-Önal, Y., Cationic PLA nanoparticles for DNA delivery: comparison of three surface polycations for DNA binding, protection and transfection properties. Colloids Surf. B: Biointerfaces 43 (2005), 163–173.
88. [88] Chen, C.K., Jones, C.H., Mistriotis, P., Yu, Y., Ma, X., Ravikrishnan, A., Jiang, M., Andreadis, S.T., Pfeifer, B.A., Cheng, C., Poly(ethylene glycol)-block-cationic polylactide nanocomplexes of differing charge density for gene delivery. Biomaterials 34 (2013), 9688–9699.
89. [89] Basarkar, A., Devineni, D., Palaniappan, R., Singh, J., Preparation, characterization, cytotoxicity and transfection efficiency of poly(dl-lactide-co-glycolide) and poly(dl-lactic acid) cationic nanoparticles for controlled delivery of plasmid DNA. Int. J. Pharm. 343 (2007), 247–254.
90. [90] Yang, X.-Z., Dou, S., Sun, T.-M., Mao, C.-Q., Wang, H.-X., Wang, J., Systemic delivery of siRNA with cationic lipid assisted PEG–PLA nanoparticles for cancer therapy. J. Control. Release 156 (2011), 203–211.
91. [91] Gu, G., Hu, Q., Feng, X., Gao, X., Menglin, J., Kang, T., Jiang, D., Song, Q., Chen, H., Chen, J., PEG–PLA nanoparticles modified with APTEDB peptide for enhanced anti-angiogenic and anti-glioma therapy. Biomaterials 35 (2014), 8215–8226.
92. [92] Gaspar, V.M., Baril, P., Costa, E.C., de Melo-Diogo, D., Foucher, F., Queiroz, J.A., Sousa, F., Pichon, C., Correia, I.J., Bioreducible poly(2-ethyl-2-oxazoline)-PLA-PEI-SS triblock copolymer micelles for co-delivery of DNA minicircles and Doxorubicin. J. Control. Release 213 (2015), 175–191.
93. [93] Yu, X.J., Luo, C., Lin, J.C., Hao, P., He, Y.Y., Guo, Z.M., Qin, L., Su, J., Liu, B.S., Huang, Y., Nan, P., Li, C.S., Xiong, B., Luo, X.M., Zhao, G.P., Pei, G., Chen, K.X., Shen, X., Shen, J.H., Zou, J.P., He, W.Z., Shi, T.L., Zhong, Y., Jiang, H.L., Li, Y.X., Putative hAPN receptor binding sites in SARS_CoV spike protein. Acta Pharmacol. Sin. 24 (2003), 481–488.
94. [94] Thermet, A., Rollier, C., Zoulim, F., Trepo, C., Cova, L., Progress in DNA vaccine for prophylaxis and therapy of hepatitis B. Vaccine 21 (2003), 659–662.
95. [95] Liu, Y., Chen, X., Wang, L., Yang, T., Yuan, Q., Ma, G., Surface charge of PLA microparticles in regulation of antigen loading, macrophage phagocytosis and activation, and immune effects in vitro. Particuology 17 (2014), 74–80.
96. [96] Gupta, R.K., Goswami, D.G., Singh, R.R., Surolia, A., Panda, A.K., Soybean agglutinin coated PLA particles entrapping candidate vaccines induces enhanced primary and sustained secondary antibody response from single point immunization. Eur. J. Pharm. Sci. 45 (2012), 282–295.
97. [97] Johansen, P., Moon, L., Tamber, H., Merkle, H.P., Gander, B., Sesardic, D., Immunogenicity of single-dose diphtheria vaccines based on PLA/PLGA microspheres in guinea pigs. Vaccine 18 (1999), 209–215.
98. [98] Guillon, C., Mayol, K., Terrat, C., Compagnon, C., Primard, C., Charles, M.-H., Delair, T., Munier, S., Verrier, B., Formulation of HIV-1 Tat and p24 antigens by PLA nanoparticles or MF59 impacts the breadth, but not the magnitude, of serum and faecal antibody responses in rabbits. Vaccine 25 (2007), 7491–7501.
99. [99] Walsh, M.C., Banas, J.A., Mudzinski, S.P., Preissler, M.T., Graziano, R.F., Gosselin, E.J., A two-component modular approach for enhancing T-cell activation utilizing a unique anti-FcgammaRI-streptavidin construct and microspheres coated with biotinylated-antigen. Biomol. Eng. 20 (2003), 21–33.
100. [100] Climent, N., Munier, S., Piqué, N., García, F., Pavot, V., Primard, C., Casanova, V., Gatell, J.M., Verrier, B., Gallart, T., Loading dendritic cells with PLA-p24 nanoparticles or MVA expressing HIV genes induces HIV-1-specific T cell responses. Vaccine 32 (2014), 6266–6276.
101. [101] Jain, A.K., Goyal, A.K., Mishra, N., Vaidya, B., Mangal, S., Vyas, S.P., PEG–PLA–PEG block copolymeric nanoparticles for oral immunization against hepatitis B. Int. J. Pharm. 387 (2010), 253–262.
102. [102] Bansal, V., Kumar, M., Dalela, M., Brahmne, H.G., Singh, H., Evaluation of synergistic effect of biodegradable polymeric nanoparticles and aluminum based adjuvant for improving vaccine efficacy. Int. J. Pharm. 471 (2014), 377–384.
103. [103] Lee, W.-k., Park, J.-y., Yang, E.H., Suh, H., Kim, S.H., Chung, D.S., Choi, K., Yang, C.W., Park, J.-s., Investigation of the factors influencing the release rates of cyclosporin A-loaded micro- and nanoparticles prepared by high-pressure homogenizer. J. Control. Release 84 (2002), 115–123.
104. [104] Tan, Q., Jiang, R., Xu, M., Liu, G., Li, S., Zhang, J., Nanosized sustained-release pyridostigmine bromide microcapsules: process optimization and evaluation of characteristics. Int. J. Nanomedicine 8 (2013), 737–745.
105. [105] Jiang, W., Schwendeman, S.P., Stabilization and controlled release of bovine serum albumin encapsulated in poly(D, L-lactide) and poly(ethylene glycol) microsphere blends. Pharm. Res. 18 (2001), 878–885.
106. [106] Elvassore, N., Bertucco, A., Caliceti, P., Production of insulin-loaded poly(ethylene glycol)/poly(l-lactide) (PEG/PLA) nanoparticles by gas antisolvent techniques. J. Pharm. Sci. 90 (2001), 1628–1636.
107. [107] Caliceti, P., Salmaso, S., Elvassore, N., Bertucco, A., Effective protein release from PEG/PLA nano-particles produced by compressed gas anti-solvent precipitation techniques. J. Control. Release 94 (2004), 195–205.
108. [108] Mimi, N., Belkacemi, H., Sadoun, T., Sapin, A., Maincent, P., How the composition and manufacturing parameters affect insulin release from polymeric nanoparticles. J. Drug Delivery Sci. Technol. 30 (2015), 458–466 (Part B).
109. [109] Ruan, G., Feng, S.-S., Preparation and characterization of poly(lactic acid)–poly(ethylene glycol)–poly(lactic acid) (PLA–PEG–PLA) microspheres for controlled release of paclitaxel. Biomaterials 24 (2003), 5037–5044.
110. [110] Adesina, S.K., Holly, A., Kramer-Marek, G., Capala, J., Akala, E.O., Polylactide-based paclitaxel-loaded nanoparticles fabricated by dispersion polymerization: characterization, evaluation in cancer cell lines, and preliminary biodistribution studies. J. Pharm. Sci. 103 (2014), 2546–2555.
111. [111] Cosco, D., Paolino, D., De Angelis, F., Cilurzo, F., Celia, C., Di Marzio, L., Russo, D., Tsapis, N., Fattal, E., Fresta, M., Aqueous-core PEG-coated PLA nanocapsules for an efficient entrapment of water soluble anticancer drugs and a smart therapeutic response. Eur. J. Pharm. Biopharm. 89 (2015), 30–39.
112. [112] Tan, G.-R., Feng, S.-S., Leong, D.T., The reduction of anti-cancer drug antagonism by the spatial protection of drugs with PLA–TPGS nanoparticles. Biomaterials 35 (2014), 3044–3051.
113. [113] Yoshizawa, H., Nishino, S., Shiomori, K., Natsugoe, S., Aiko, T., Kitamura, Y., Surface morphology control of polylactide microspheres enclosing irinotecan hydrochloride. Int. J. Pharm. 296 (2005), 112–116.
114. [114] Freitas, M.N., Marchetti, J.M., Nimesulide PLA microspheres as a potential sustained release system for the treatment of inflammatory diseases. Int. J. Pharm. 295 (2005), 201–211.
115. [115] Vila, A., Sánchez, A., Évora, C., Soriano, I., McCallion, O., Alonso, M.J., PLA–PEG particles as nasal protein carriers: the influence of the particle size. Int. J. Pharm. 292 (2005), 43–52.
116. [116] Dalmolin, L.F., Khalil, N.M., Mainardes, R.M., Delivery of vanillin by poly(lactic-acid) nanoparticles: development, characterization and in vitro evaluation of antioxidant activity. Mater. Sci. Eng. C 62 (2016), 1–8.
117. [117] Sheng, Y., Yuan, Y., Liu, C., Tao, X., Shan, X., Xu, F., In vitro macrophage uptake and in vivo biodistribution of PLA–PEG nanoparticles loaded with hemoglobin as blood substitutes: effect of PEG content. J. Mater. Sci. Mater. Med. 20 (2009), 1881–1891.
118. [118] Zambaux, M.F., Bonneaux, F., Gref, R., Dellacherie, E., Vigneron, C., Preparation and characterization of protein C-loaded PLA nanoparticles. J. Control. Release 60 (1999), 179–188.
119. [119] Lee, S.H., Zhang, Z., Feng, S.-S., Nanoparticles of poly(lactide)—tocopheryl polyethylene glycol succinate (PLA–TPGS) copolymers for protein drug delivery. Biomaterials 28 (2007), 2041–2050.
120. [120] Cheng, Q., Feng, J., Chen, J., Zhu, X., Li, F., Brain transport of neurotoxin-I with PLA nanoparticles through intranasal administration in rats: a microdialysis study. Biopharm. Drug Dispos. 29 (2008), 431–439.
121. [121] Pinon-Segundo, E., Ganem-Quintanar, A., Alonso-Perez, V., Quintanar-Guerrero, D., Preparation and characterization of triclosan nanoparticles for periodontal treatment. Int. J. Pharm. 294 (2005), 217–232.
122. [122] Hu, K., Li, J., Shen, Y., Lu, W., Gao, X., Zhang, Q., Jiang, X., Lactoferrin-conjugated PEG–PLA nanoparticles with improved brain delivery: in vitro and in vivo evaluations. J. Control. Release 134 (2009), 55–61.
123. [123] Nguyen, C.A., Allémann, E., Schwach, G., Doelker, E., Gurny, R., Cell interaction studies of PLA–MePEG nanoparticles. Int. J. Pharm. 254 (2003), 69–72.
124. [124] Leroux, J.-C., Allémann, E., De Jaeghere, F., Doelker, E., Gurny, R., Biodegradable nanoparticles—from sustained release formulations to improved site specific drug delivery. J. Control. Release 39 (1996), 339–350.
125. [125] Thomasin, C., Merkle, H.P., Gander, B.A., Physico-chemical parameters governing protein microencapsulation into biodegradable polyesters by coacervation. Int. J. Pharm. 147 (1997), 173–186.
126. [126] Pandey, S.K., Ghosh, S., Maiti, P., Haldar, C., Therapeutic efficacy and toxicity of tamoxifen loaded PLA nanoparticles for breast cancer. Int. J. Biol. Macromol. 72 (2015), 309–319.
127. [127] Barwal, I., Sood, A., Sharma, M., Singh, B., Yadav, S.C., Development of stevioside Pluronic-F-68 copolymer based PLA-nanoparticles as an antidiabetic nanomedicine. Colloids Surf. B: Biointerfaces 101 (2013), 510–516.
128. [128] Jeevitha, D., Amarnath, K., Chitosan/PLA nanoparticles as a novel carrier for the delivery of anthraquinone: synthesis, characterization and in vitro cytotoxicity evaluation. Colloids Surf. B: Biointerfaces 101 (2013), 126–134.
129. [129] Xiong, X.Y., Li, Y.P., Li, Z.L., Zhou, C.L., Tam, K.C., Liu, Z.Y., Xie, G.X., Vesicles from pluronic/poly(lactic acid) block copolymers as new carriers for oral insulin delivery. J. Control. Release 120 (2007), 11–17.
130. [130] Aline, F., Brand, D., Pierre, J., Roingeard, P., Séverine, M., Verrier, B., Dimier-Poisson, I., Dendritic cells loaded with HIV-1 p24 proteins adsorbed on surfactant-free anionic PLA nanoparticles induce enhanced cellular immune responses against HIV-1 after vaccination. Vaccine 27 (2009), 5284–5291.
131. [131] Guerrero, S., Muniz, E., Teijon, C., Olmo, R., Teijon, J.M., Blanco, M.D., Ketotifen-loaded microspheres prepared by spray-drying poly(D,L-lactide) and poly(D,L-lactide-co-glycolide) polymers: characterization and in vivo evaluation. J. Pharm. Sci. 97 (2008), 3153–3169.
132. [132] Rungseevijitprapa, W., Brazeau, G.A., Simkins, J.W., Bodmeier, R., Myotoxicity studies of O/W-in situ forming microparticle systems. Eur. J. Pharm. Biopharm. 69 (2008), 126–133.
133. [133] Geng, Z., Luo, X., Zhang, Z., Li, H., Tian, J., Yu, Z., Study of an injectable in situ forming gel for sustained-release of Ivermectin in vitro and in vivo. Int. J. Biol. Macromol. 85 (2016), 271–276.
134. [134] Kranz, H., Bodmeier, R., A novel in situ forming drug delivery system for controlled parenteral drug delivery. Int. J. Pharm. 332 (2007), 107–114.
135. [135] Kranz, H., Bodmeier, R., Structure formation and characterization of injectable drug loaded biodegradable devices: in situ implants versus in situ microparticles. Eur. J. Pharm. Sci. 34 (2008), 164–172.
136. [136] Pitarresi, G., Palumbo, F.S., Fiorica, C., Calascibetta, F., Di Stefano, M., Giammona, G., Injectable in situ forming microgels of hyaluronic acid-g-polylactic acid for methylprednisolone release. Eur. Polym. J. 49 (2013), 718–725.
137. [137] Anderson, L.C., Wise, D.L., Howes, J.F., An injectable sustained release fertility control system. Contraception 13 (1976), 375–384.
138. [138] Nykamp, G., Carstensen, U., Müller, B.W., Jet milling—a new technique for microparticle preparation. Int. J. Pharm. 242 (2002), 79–86.
139. [139] Yolles, S., Leafe, T.D., Woodland, J.H., Meyer, F.J., Long acting delivery systems for narcotic antagonists II: release rates of naltrexone from poly(lactic acid) composites. J. Pharm. Sci. 64 (1975), 348–349.
140. [140] Smith, A., Hunneyball, I.M., Evaluation of poly(lactic acid) as a biodegradable drug delivery system for parenteral administration. Int. J. Pharm. 30 (1986), 215–220.
141. [141] Li, D., Guo, G., Fan, R., Liang, J., Deng, X., Luo, F., Qian, Z., PLA/F68/dexamethasone implants prepared by hot-melt extrusion for controlled release of anti-inflammatory drug to implantable medical devices: I. Preparation, characterization and hydrolytic degradation study. Int. J. Pharm. 441 (2013), 365–372.
142. [142] Bleich, J., Muller, B.W., Production of drug loaded microparticles by the use of supercritical gases with the aerosol solvent extraction system (ASES) process. J. Microencapsul. 13 (1996), 131–139.
143. [143] Whitaker, M.J., Hao, J., Davies, O.R., Serhatkulu, G., Stolnik-Trenkic, S., Howdle, S.M., Shakesheff, K.M., The production of protein-loaded microparticles by supercritical fluid enhanced mixing and spraying. J. Control. Release 101 (2005), 85–92.
144. [144] Falk, R., Randolph, T.W., Meyer, J.D., Kelly, R.M., Manning, M.C., Controlled release of ionic compounds from poly (l-lactide) microspheres produced by precipitation with a compressed antisolvent. J. Control. Release 44 (1997), 77–85.
145. [145] He, T., Liang, Q., Zhang, K., Mu, X., Luo, T., Wang, Y., Luo, G., A modified microfluidic chip for fabrication of paclitaxel-loaded poly(l-lactic acid) microspheres. Microfluid. Nanofluid. 10 (2011), 1289–1298.
146. [146] van de Weert, M., Hennink, W.E., Jiskoot, W., Protein instability in poly(lactic-co-glycolic acid) microparticles. Pharm. Res. 17 (2000), 1159–1167.
147. [147] Katou, H., Wandrey, A.J., Gander, B., Kinetics of solvent extraction/evaporation process for PLGA microparticle fabrication. Int. J. Pharm. 364 (2008), 45–53.
148. [148] Thomasin, C., Ho, N.T., Merkle, H.P., Gander, B., Drug microencapsulation by PLA/PLGA coacervation in the light of thermodynamics. 1. Overview and theoretical considerations. J. Pharm. Sci. 87 (1998), 259–268.
149. [149] Astete, C.E., Sabliov, C.M., Synthesis and characterization of PLGA nanoparticles. J. Biomater. Sci. Polym. Ed. 17 (2006), 247–289.
150. [150] Yun, Y.H., Lee, B.K., Park, K., Controlled drug delivery: historical perspective for the next generation. J. Control. Release 219 (2015), 2–7.
151. [151] Sah, H., Thoma, L.A., Desu, H.R., Sah, E., Wood, G.C., Concepts and practices used to develop functional PLGA-based nanoparticulate systems. Int. J. Nanomedicine 8 (2013), 747–765.
152. [152] Ma, G., Microencapsulation of protein drugs for drug delivery: strategy, preparation, and applications. J. Control. Release 193 (2014), 324–340.
153. [153] Palacio, J., Agudelo, N.A., Lopez, B.L., PEGylation of PLA nanoparticles to improve mucus-penetration and colloidal stability for oral delivery systems. Curr. Opin. Chem. Eng. 11 (2016), 14–19.